Metro Vein Centers Executive and Leadership Team

Michael Wendt, the Chief Financial Officer at Metro Vein Centers, manages the fiscal health and strategic investment planning for the organization. Wendt oversees the integration of over 200 insurance plans into the billing infrastructure, ensuring that vein care remains accessible to a broad client base. By analyzing revenue cycles and operational costs, the Chief Financial Officer maintains the financial stability required to support the expansion of clinical locations. This role involves collaborating with the executive team to allocate capital toward advanced medical technology and facility upgrades. Michael Wendt directs financial reporting and compliance efforts to uphold the company's high standards of transparency. Through careful management of fiscal resources, the Chief Financial Officer supports the long-term sustainability of the business model. Wendt secures the financial foundation necessary for the continued delivery of innovative, minimally invasive treatments to patients nationwide.

Geet Punjabi, the Chief of Staff at Metro Vein Centers, directs internal operations and coordinates cross-functional initiatives to optimize clinic performance. Punjabi manages the alignment of administrative workflows with the broader organizational mission of providing high-quality vascular care. By streamlining communication between departments, the Chief of Staff ensures that operational goals remain consistent with the company's commitment to patient satisfaction. This leadership role involves overseeing resource allocation and supporting the executive team in executing long-term growth strategies across the United States. Geet Punjabi monitors key performance indicators to maintain the 98% satisfaction rate achieved by the organization. Through rigorous process improvement, the Chief of Staff drives efficiency in patient intake and clinical scheduling. Ultimately, Punjabi fosters a culture of excellence that supports the delivery of state-of-the-art vein treatments to a diverse patient population.

Philip LoPresti, the Chief Medical Officer at Metro Vein Centers, directs clinical standards and ensures the delivery of high-quality care across all medical facilities. LoPresti oversees the recruitment and training of board-certified vein specialists to maintain the company's reputation for excellence. By establishing evidence-based protocols for the treatment of varicose and spider veins, the Chief Medical Officer guarantees consistent patient outcomes. This leadership role involves monitoring clinical performance metrics and implementing quality assurance programs to uphold the 98% satisfaction rate. Philip LoPresti collaborates with the executive team to integrate new medical technologies into the existing service offerings. Through the oversight of clinical governance, the Chief Medical Officer drives the adoption of best practices in vascular medicine. LoPresti ensures that every clinic operates with a focus on patient safety and effective, minimally invasive solutions for venous conditions.

Mason Mandy, the Surgeon, Chief Medical Officer at Metro Vein Centers, architects the surgical strategy and clinical innovation roadmap for the organization. Mandy focuses on the technical advancement of minimally invasive procedures, ensuring that the surgical team utilizes the most effective techniques for treating complex venous disease. As the Surgeon, Chief Medical Officer, Mandy evaluates new medical devices and surgical methodologies to enhance patient recovery times and overall results. This role involves mentoring clinical staff and fostering a culture of continuous learning within the surgical departments. Mason Mandy works closely with the executive leadership to expand the reach of specialized vein care into new regional markets. By prioritizing surgical precision and patient-centered care, the Surgeon, Chief Medical Officer drives the clinical success of the company. Mandy maintains rigorous standards for all surgical interventions, ensuring that every patient receives top-tier care.